Rus Eng
Main / Company's news / Import Substitution and Localisation Centre opened in Saint Petersburg

Import Substitution and Localisation Centre opened in Saint Petersburg

10 September 2015

On September 10 the fourth pavilion at the Lenexpo Exhibition Complex witnessed the official opening of the Import-Substitution and Localisation Centre. The opening ceremony was attended by Valentina Matvienko, Speaker of the Federation Council, Georgiy Poltavchenko, St. Petersburg Governor, and Vyacheslav Makarov, Speaker of the St. Petersburg Legislative Assembly.

The main objective of the Centre is to create an effective platform for practical implementation of import substitution programmes aimed to stimulate the localisation growth, facilitate the development of enterprises in St. Petersburg and Northwestern Federal District and build effective dialogue between the authorities and manufacturers/suppliers and customers. The Centre will become the first and unique communication site of this kind in Russia.

An exhibition area was organized in the Centre in order to demonstrate the scientific, technological and production potential of enterprises. After the grand opening ceremony, honourable guests took a tour around the pavilion.

The leading Russian pharmaceutical companies participated in the exhibition: GEROPHARM Group of Companies presented the entire range of the manufactured products on its stand: Cortexin®, Cortexin® for children (neurology), Retinalamin® (ophthalmology) - original. Russian drug products, and some generics important in terms of import substitution: Levetinol® and Memantinol®.

Honoured guests paid special attention to the genetically engineered human insulins: Rinsulin® R and Rinsulin® NPH. These socially significant drug products are manufactured at the GEROPHARM-Bio factory using full cycle principle: from the substance synthesis to the finished dosage form, which guarantees stability of product release and allows to perform complex quality control at all production stages. Today these drug products are manufactured in all modern product forms: vials, cartridges, autoinjectors and are supplied to almost every region of Russia,

While showing drug samples to Valentina Matvienko, Speaker of the Federation Council, and Georgiy Poltavchenko, St. Petersburg Governor, Petr Rodionov has noted that today GEROPHARM is the only full-cycle manufacturer of insulins having such unique competences. The company plans to develop insulin analogues and their production technologies based on the full cycle principle. This will improve drug safety of the country and increase availability of socially significant drug products for patients.

You are a health care professional?

Go up